The EACH/PIC Coalition submitted comments to the Maryland PDAB on the proposed rule governing the implementation and monitoring of upper payment limits (UPLs) implemented by the board. The letter stated: […]
The EACH/PIC Coalition submitted comments to the Washington PDAB urging the board to focus their affordability reviews on patient-reported hardships and examining the results of the Advisory Group reports published
The EACH/PIC Coalition submitted comments to the Oregon PDAB, providing input into policy recommendations to consider for inclusion in the 2026 annual report to the legislature and a standing form
The EACH/PIC Coalition submitted a group letter signed by 22 organizations to the Maryland PDAD in response to proposed regulations defining the circumstances under which use of a drug may
The EACH/PIC Coalition submitted a group letter signed by 25 organizations opposing the creation of an upper payment limit for Cosentyx. The letter stated: “We support efforts to improve affordability
The EACH/PIC Coalition submitted comments to the Oregon PDAB, providing input into policy recommendations to consider for inclusion in the 2026 annual report to the legislature. The letter stated: “Throughout
The EACH/PIC Coalition submitted a letter to the Louisiana Governor Jeff Landry opposing the creation of a PDAB in the state and urging for the bill to be vetoed. The
The EACH/PIC Coalition submitted a letter to the Maryland PDAB in response to proposed changes to the Cost Review Study Process. The letter stated: “Ultimately, the board’s cost review is
May 21, 2026 The EACH/PIC Coalition issued the following statement on Most-Favored-Nation-style price-setting policies: “The EACH/PIC Coalition remains concerned that most favored nation proposals are unlikely to deliver meaningful savings
May 19, 2026 Mark Hobraczk, legislative lead for the EACH/PIC Coalition, issued the following statement in response to Governor Abigail Spanberger’s veto of H.B. 483 / S.B. 271: “Governor Spanberger
